^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
QuantideX® qPCR ESR1 exoMutation Kit

Company:
Bio-Techne
Type:
Laboratory Developed Test
Related tests:
Evidence

News

1m
Bio-Techne to highlight novel solutions for cancer and carrier screening at AMP 2024 annual meeting & expo (Bio-Techne Press Release)
"Bio-Techne Corporation...today announced its lineup of presentations and activities for the Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo, taking place November 19-23 in Vancouver, British Columbia. Asuragen, a Bio-Techne brand, will be exhibiting and showcasing its latest research products for breast cancer monitoring and carrier screening in booth #811."
Clinical data
|
AmplideX® Nanopore Carrier Plus Kit • ExoLution™ Plus cfDNA + exoRNA Isolation Kit • QuantideX® qPCR ESR1 exoMutation Kit